jade1 Antibody

What is JADE1 and what are its key biological characteristics?

JADE1 (jade family PHD finger 1) is a multifunctional nuclear and cytoplasmic protein with a canonical length of 842 amino acid residues and a molecular mass of approximately 95.5 kDa in humans. It exists in up to three different isoforms and functions primarily as a scaffold subunit of HBO1 complexes, which exhibit histone H4 acetyltransferase activity. JADE1 is highly expressed in the kidney and has been identified as a component of chromatin modification complexes. The protein contains PHD finger domains that are characteristic of chromatin-associated proteins involved in transcriptional regulation. JADE1 is also known by several synonyms including PHD finger protein 17, PHD protein Jade-1, gene for apoptosis and differentiation in epithelia, and protein Jade-1 .

What are the recommended applications for JADE1 antibodies in epigenetic research?

JADE1 antibodies are valuable tools for investigating epigenetic regulation mechanisms, particularly in studying the HBO1 histone acetyltransferase complex. The primary applications include Western blot analysis for protein expression levels, immunofluorescence for subcellular localization studies, and immunohistochemistry for tissue distribution patterns . For epigenetic research specifically, JADE1 antibodies can be employed in chromatin immunoprecipitation (ChIP) assays to investigate JADE1's association with specific genomic regions, although researchers have reported challenges with direct Jade1 ChIP-seq . Additionally, JADE1 antibodies can be used in co-immunoprecipitation experiments to identify protein interaction partners within chromatin-modifying complexes. When studying the role of JADE1 in histone modification, researchers should consider combining JADE1 antibodies with antibodies against specific histone marks, particularly H4K5ac, H4K8ac, and H4K12ac, which are substrates of the JADE1-HBO1 complex .

How should researchers optimize Western blot protocols for JADE1 detection?

For optimal Western blot detection of JADE1, researchers should implement several critical protocol modifications. First, given JADE1's molecular weight of 95.5 kDa, use 8-10% polyacrylamide gels for adequate separation. During sample preparation, employ a nuclear extraction protocol since JADE1 is predominantly found in nuclear fractions. A recommended nuclear extraction buffer composition would include 20 mM HEPES pH 8.0, 25% glycerol, 1.5 mM MgCl₂, 420 mM KCl, 0.25% NP-40, 0.2 mM EDTA, and 0.5 mM dithiothreitol supplemented with protease inhibitors . For protein transfer, use a wet transfer system at lower voltage (30V) overnight at 4°C to ensure efficient transfer of high molecular weight JADE1. When blocking, 5% non-fat milk in TBST for 1-2 hours at room temperature is typically sufficient. For immunodetection, dilute primary anti-JADE1 antibody at 1:1000 in 5% BSA/TBST and incubate overnight at 4°C. After washing with TBST, apply HRP-conjugated secondary antibody (anti-rabbit IgG) at 1:5000 dilution for 1 hour at room temperature. Enhanced chemiluminescence detection systems offer good sensitivity for visualizing JADE1 bands .

What are the critical parameters for successful immunofluorescence detection of JADE1?

Successful immunofluorescence detection of JADE1 requires careful attention to several key parameters. Cell fixation should be performed using 4% paraformaldehyde for 15 minutes at room temperature, as this preserves both nuclear and cytoplasmic JADE1 localization. Permeabilization is best achieved with 0.25% Triton X-100 in PBS for 10 minutes. When blocking, use 5% normal goat serum in PBS with 0.1% Tween-20 for 1 hour at room temperature. For primary antibody incubation, dilute anti-JADE1 antibody at 1:100-1:200 in blocking buffer and incubate overnight at 4°C in a humidified chamber. Following thorough washing with PBS containing 0.1% Tween-20, apply fluorophore-conjugated secondary antibody (FITC-conjugated anti-rabbit IgG) at 1:500 dilution for 1 hour at room temperature in the dark. Counterstain nuclei with DAPI (as demonstrated in validation images with U2OS cells) . For colocalization studies with chromatin factors, consider dual immunostaining with antibodies against histone marks or other epigenetic regulators. Confocal microscopy with z-stack acquisition is recommended for precise subcellular localization analysis of JADE1, particularly when examining its distribution between nuclear and cytoplasmic compartments.

What controls should be included when working with JADE1 antibodies in ChIP experiments?

When conducting ChIP experiments with JADE1 antibodies, implementing a comprehensive set of controls is essential for generating reliable and interpretable data. First, include input DNA controls (typically 1-5% of starting chromatin) to normalize enrichment and account for technical variations. Second, implement IgG negative controls using the same host species as the JADE1 antibody to establish background signal levels. Third, incorporate positive controls targeting regions known to bind JADE1 or its complex partner HBO1, such as promoters of genes like Polr2a, Zmiz2, and Rras2 . Fourth, use validated antibodies against known JADE1 interaction partners (such as HBO1) to confirm co-occupancy at specific genomic loci. Fifth, if studying JADE1's role in the HBO1 complex, include ChIP for histone modifications catalyzed by this complex (H4K5ac, H4K8ac, H4K12ac) to correlate JADE1 binding with functional outcomes . Additionally, researchers may consider spike-in controls with chromatin from a different species for quantitative normalization. Given the reported challenges with direct JADE1 ChIP-seq, optimization of crosslinking conditions (try both formaldehyde and dual crosslinkers), sonication parameters, and antibody concentrations is critical for successful outcomes.

How does JADE1 contribute to the substrate specificity of the HBO1 histone acetyltransferase complex?

JADE1 plays a critical role in determining the substrate specificity of the HBO1 histone acetyltransferase complex through multiple mechanisms. As demonstrated in biochemical studies, the purified JADE1L/HBO1 complex selectively acetylates specific lysine residues on histone H4, particularly H4K5, H4K8, and H4K12, while notably not modifying H4K16 . This specificity is distinct from the pattern observed when HBO1 associates with alternative scaffold proteins like BRPF1, which redirects activity toward histone H3K14. JADE1 appears to function as a scaffold subunit that properly positions HBO1 catalytic activity toward its appropriate histone substrates. The PHD finger domains in JADE1 likely contribute to this specificity by recognizing histone modifications or unmodified histones and directing the enzymatic activity of the complex. Importantly, recent research has revealed that JADE1 and HBO1 preferentially associate with Oct4 at MORE (Multiple Oct-factor Recognition Elements) sites rather than octamer binding sites in embryonic stem cells, suggesting that JADE1 also influences genomic targeting of the HBO1 complex, thereby indirectly affecting substrate specificity .

What is the functional relationship between JADE1, HBO1, and transcription factors like Oct4 in stem cell biology?

The functional relationship between JADE1, HBO1, and transcription factors like Oct4 represents a sophisticated mechanism of epigenetic regulation in stem cell biology. Recent research has uncovered that JADE1 and the HBO1 complex function as spatial-selective cofactors of Oct4, preferentially associating with MORE (Multiple Oct-factor Recognition Elements) rather than octamer motifs in embryonic stem cells . This selective co-localization was demonstrated through HBO1 ChIP-seq, which revealed that approximately 1,744 HBO1 peaks overlapped with Oct4 binding sites. Remarkably, the average distance between Oct4 bound at MORE sites and the nearest HBO1 peak was less than 200 bp, compared to more than 10 kb for general Oct4 binding sites . This selective recruitment suggests that JADE1/HBO1 specifically modulates Oct4 function at MORE-containing genes rather than acting as a general Oct4 cofactor. Functionally, this interaction likely impacts the pluripotency network, as Oct4 is a master regulator of stem cell identity. The histone H4 acetylation mediated by the JADE1/HBO1 complex at these sites (specifically H4K5ac, H4K8ac, and H4K12ac) potentially creates a permissive chromatin environment for gene expression regulation by Oct4, thereby influencing stem cell maintenance and differentiation programs .

How can researchers distinguish between different JADE1 isoforms in experimental systems?

Distinguishing between the three reported JADE1 isoforms presents a significant challenge that requires a combination of methodological approaches. Western blot analysis using antibodies that recognize common regions can detect all isoforms, but size-based differentiation is critical - researchers should optimize gel separation conditions to resolve the distinct molecular weights of each isoform. The canonical JADE1 protein has a reported mass of 95.5 kDa, while other isoforms may migrate differently . For more precise isoform characterization, researchers should implement isoform-specific RT-PCR using primers targeting unique exon junctions or sequences specific to each variant. RNA-seq analysis with appropriate bioinformatic pipelines can quantify isoform-specific expression levels across different tissues or experimental conditions. For protein-level discrimination, researchers might consider using isoform-specific antibodies if the isoforms contain unique epitope regions. Alternatively, mass spectrometry analysis following immunoprecipitation can identify peptides unique to specific isoforms. When studying functional differences between isoforms, isoform-specific knockdown or overexpression followed by rescue experiments with individual isoforms can reveal distinct biological roles. Finally, fluorescent tagging of specific isoforms can enable visualization of potentially different subcellular localizations or interaction partners.

Why might JADE1 ChIP-seq experiments fail while HBO1 ChIP-seq succeeds in the same experimental system?

The differential success rates between JADE1 and HBO1 ChIP-seq experiments in identical systems stem from multiple technical and biological factors. As noted in the literature, researchers "attempted to determine Jade1 binding preferences genome-wide using Jade1 ChIP-seq with an anti-Jade1 antibody without success" and subsequently "turned to ChIP using antibodies against the HBO1 subunit" with successful outcomes . This discrepancy likely reflects several challenges: First, antibody quality and epitope accessibility vary substantially - HBO1 antibodies may recognize exposed epitopes while JADE1 epitopes might be masked within protein complexes when bound to chromatin. Second, crosslinking efficiency differs between proteins - standard formaldehyde crosslinking may inadequately capture JADE1-chromatin interactions, while HBO1 may crosslink more efficiently. Third, JADE1 might associate with chromatin more transiently than HBO1, making its interactions more difficult to capture. Fourth, the stoichiometry of JADE1 within the HBO1 complex could result in fewer JADE1 molecules per chromatin region compared to HBO1. Fifth, JADE1 might undergo post-translational modifications at chromatin that interfere with antibody recognition. To overcome these limitations, researchers should consider alternative crosslinking methods (such as DSG plus formaldehyde), optimize sonication conditions, try multiple antibodies targeting different JADE1 epitopes, and potentially implement ChIP protocols optimized for transcription factors rather than standard histone ChIP protocols.

What are the potential causes and solutions for non-specific bands when performing Western blot with JADE1 antibodies?

Non-specific bands in JADE1 Western blots can result from multiple factors that require systematic troubleshooting. First, JADE1 isoforms (up to three reported variants) may appear as distinct bands that could be misinterpreted as non-specific signals . Researchers should verify the molecular weights of all known isoforms and compare them with observed bands. Second, post-translational modifications of JADE1, including phosphorylation or ubiquitination, can alter migration patterns. To address this, samples can be treated with phosphatases or deubiquitinating enzymes prior to electrophoresis. Third, partial protein degradation during sample preparation may generate fragments that retain the antibody epitope. This can be mitigated by using fresh samples, maintaining cold temperatures throughout preparation, and adding multiple protease inhibitors to extraction buffers . Fourth, the antibody itself may cross-react with structurally similar proteins, particularly other PHD-finger-containing proteins. To overcome this, implement more stringent blocking conditions (5% BSA instead of milk) and optimize primary antibody dilution (typically 1:1000 in 5% BSA/TBST is recommended) . Fifth, excessive antibody concentration can increase background. Titrate antibody concentrations and include a peptide competition assay to confirm specificity. Finally, insufficient washing can contribute to non-specific signals. Implement more rigorous washing steps with TBST (at least 3 x 10 minutes) after both primary and secondary antibody incubations.

How can researchers accurately interpret apparent contradictions in JADE1 localization between immunofluorescence and biochemical fractionation data?

Reconciling contradictory JADE1 localization data between immunofluorescence (IF) and biochemical fractionation requires careful methodological consideration and nuanced interpretation. When faced with such discrepancies, researchers should first recognize that both techniques have distinct limitations and provide complementary rather than redundant information. Immunofluorescence provides spatial resolution at the single-cell level but may suffer from epitope masking in specific cellular compartments, fixation artifacts, or antibody accessibility issues . Conversely, biochemical fractionation offers population-level quantitative distribution but is subject to cross-contamination between fractions and extraction efficiency variations. To resolve these contradictions, researchers should implement several approaches: First, perform time-course experiments to determine if JADE1 shuttles between compartments under specific conditions. Second, use multiple antibodies targeting different JADE1 epitopes to rule out epitope-specific accessibility issues. Third, complement standard IF with proximity ligation assays to validate protein-protein interactions in specific compartments. Fourth, implement live-cell imaging with fluorescently-tagged JADE1 to monitor dynamic localization changes. Fifth, compare different fractionation protocols that vary in stringency to determine if JADE1 association with specific compartments is labile or stable. Finally, researchers should consider that JADE1 is reported to localize in both nuclear and cytoplasmic compartments , suggesting that observed contradictions may reflect genuine biological complexity rather than technical artifacts.

What is the specific pattern of histone acetylation mediated by the JADE1/HBO1 complex?

The JADE1/HBO1 complex exhibits a highly specific pattern of histone acetylation that distinguishes it from other histone acetyltransferase complexes. Biochemical studies using purified recombinant proteins have demonstrated that the JADE1L/HBO1 complex efficiently acetylates histone H4 within nucleosomes, with remarkable specificity for particular lysine residues. Through immunoblotting with site-specific antibodies, researchers have established that this complex catalyzes acetylation at H4K5, H4K8, and H4K12 but notably not at H4K16 . This pattern is consistent with the role of JADE1 as a scaffold protein that positions the HBO1 catalytic subunit to access specific histone substrates. Interestingly, while the JADE1/HBO1 complex does not acetylate H3K14, there is some evidence suggesting possible activity toward H3K9, although cross-reactivity issues with the antibodies have complicated this interpretation . This acetylation signature is functionally distinct from that of the alternative HBO1 complex containing BRPF1, which preferentially acetylates histone H3K14 . The specific pattern of H4 acetylation mediated by the JADE1/HBO1 complex likely contributes to creating a permissive chromatin environment at target genes, facilitating transcriptional activation particularly at sites co-bound by transcription factors like Oct4.

How can researchers quantitatively assess changes in JADE1-mediated histone acetylation in response to experimental manipulations?

Researchers can employ multiple complementary approaches to quantitatively assess changes in JADE1-mediated histone acetylation following experimental manipulations. First, ChIP-seq for H4K5ac, H4K8ac, and H4K12ac (the primary targets of the JADE1/HBO1 complex) can map genome-wide changes in acetylation patterns when combined with computational analysis to identify statistically significant differences between conditions . Second, ChIP-qPCR targeting specific loci of interest (such as MORE-containing Oct4 target genes) provides targeted quantification with higher sensitivity for selected regions . Third, Western blot analysis of acid-extracted histones using site-specific acetylation antibodies can measure global changes in acetylation levels, with densitometry providing semi-quantitative assessment. Fourth, mass spectrometry-based approaches, particularly Selected Reaction Monitoring (SRM) or Parallel Reaction Monitoring (PRM), offer precise quantification of specific histone modifications with high sensitivity. Fifth, in vitro histone acetyltransferase assays using purified JADE1/HBO1 complexes and recombinant nucleosomes can directly measure enzymatic activity under different conditions, as demonstrated in the literature . For cellular systems, researchers should implement JADE1 knockdown/knockout controls alongside rescue experiments with wild-type or mutant JADE1 to establish causality. Time-course experiments following stimulation or inhibition are recommended to capture dynamic changes in acetylation. Additionally, simultaneous assessment of multiple histone marks can reveal potential crosstalk between different modifications in response to JADE1 modulation.

What methodological approaches can distinguish between direct JADE1-mediated effects on histone acetylation versus indirect effects through other pathways?

Distinguishing direct from indirect JADE1-mediated effects on histone acetylation requires a multi-faceted experimental strategy focused on establishing causality and mechanism. First, researchers should implement in vitro reconstitution experiments using purified components - recombinant JADE1, HBO1, ING4, hEaf6, and nucleosomes - to demonstrate direct acetylation activity on specific histone residues in a controlled system . Second, structure-function studies with JADE1 mutants lacking specific domains (particularly PHD fingers) can identify regions required for directing histone acetylation specificity. Third, rapid induction systems (such as auxin-inducible degrons or doxycycline-inducible expression) allow temporal analysis of acetylation changes immediately following JADE1 modulation, helping distinguish primary from secondary effects. Fourth, ChIP-seq co-localization analysis of JADE1 (or HBO1 as a proxy if JADE1 ChIP is challenging) with H4K5ac, H4K8ac, and H4K12ac can establish spatial correlation between JADE1 binding and acetylation patterns . Fifth, sequential ChIP (re-ChIP) can determine if JADE1 and acetylated histones co-occur on the same DNA fragments. Sixth, proximity-based biotinylation approaches (BioID or TurboID fused to JADE1) can identify proteins in close proximity to JADE1 in living cells, potentially revealing direct targets. Finally, researchers should perform kinetic analyses measuring the rate of acetylation changes following JADE1 perturbation - direct effects typically occur more rapidly than indirect effects mediated through transcriptional changes or secondary protein interactions.

Table 1: Histone Acetylation Specificity of JADE1/HBO1 Complex